What can cystatin C test contribute to chronic kidney disease management?

October 10, 2017

The use of cystatin C along with creatinine to estimate the glomerular filtration rate (GFR) when diagnosing chronic kidney disease (CKD) in primary care patients would result in increased health care costs and no improvement in risk prediction, according to a new study published in PLOS Medicine by Adam Shardlow of the University of Nottingham, UK and colleagues.

Estimation of GFR from creatinine may be inaccurate in some people, and potentially lead to the over-diagnosis of CKD, so international and national guideline have recently recommended confirming borderline cases of CKD with an estimation of GFR based on cystatin C. In the new study, researchers estimated GFR from serum creatinine and cystatin C in a cohort of 1741 adults diagnosed with CKD in primary care between 2008 and 2010. They compared the GFR calculated by each method both at baseline and over five years of follow-up.

The use of cystatin C to confirm a diagnosis of CKD resulted in 7.7% of people (50 of 653) being reclassified to not have CKD, but 59.0% of people (385 of 653) being reclassified to a lower eGFR, indicating more advanced CKD. In addition, change in eGFR based on cystatin C over five years identified more people as having CKD progression. However, use of cystatin C did not improve discrimination in risk prediction models, and increased the cost of monitoring by £23 per patient in the first year of implementation.

"In a primary care setting, the potential benefit of reducing over-diagnosis of CKD with [cystatin C] would be eliminated by the unintended consequence of greater reclassification to more advanced CKD, requiring more frequent monitoring and increased referrals to secondary care."
-end-
Funding:

The RRID study is currently funded by a Research Project Grant (R302/0713) from the Dunhill Medical Trust. Previous study funding includes a joint British Renal Society and Kidney Research UK fellowship (BRS3/2008, to NJM), and an unrestricted educational grant (EPWE124712-G) from Roche Products Ltd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests:

MWT is a member of the PLOS Medicine Editorial Board. RJF is Clinical CO-Chair, Internal Medicine Programme of Care, Specialised Commissioning, NHS England and chair, Think Kidneys, UK Renal Registry.

Citation:

Shardlow A, McIntyre NJ, Fraser SDS, Roderick P, Raftery J, Fluck RJ, et al. (2017) The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study. PLoS Med 14(10): e1002400. https://doi.org/10.1371/journal.pmed.1002400

Author Affiliations:

Renal Unit, Royal Derby Hospital, Derby, United Kingdom
Centre for Kidney Research and Innovation, Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, Royal Derby Hospital, Derby, United Kingdom
Academic Unit of Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
Division of Nephrology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002400

PLOS

Related Primary Care Articles from Brightsurf:

Six ways primary care "medical homes" are lowering health care spending
New analysis of 394 U.S. primary care practices identifies the aspects of care delivery that are associated with lower health care spending and lower utilization of emergency care and hospital admissions.

Continuity of English primary care has worsened with GP expansions
A new study published by the British Journal of General Practice has found that patients' abilities to see their preferred GP has fallen greater in English practices that have expanded, compared with those that stayed about the same size.

Primary care office-based vs telemedicine care visits during COVID-19 pandemic
This observational study quantified national changes in the volume, type and content of primary care delivered during the COVID-19 pandemic, especially with regard to office-based visits compared with telemedicine encounters.

Expenditures for primary care may affect how primary care is delivered
This study looks at trends in out-of-pocket and total visit expenditures for visits to primary care physicians.

Primary care clinicians drove increasing use of Medicare's chronic care management codes
To address the problem of care fragmentation for Medicare recipients with multiple chronic conditions, Medicare introduced Chronic Care Management (CCM) in 2015 to reimburse clinicians for care management and coordination.

Primary care at a crossroads: Experts call for change
Primary care providers have experienced a rise in responsibilities with little or no increase in the time they have to get it all done, or reduction in the number of patients assigned to them.

Primary care physicians during the COVID-19 epidemic
Scientists from the University of Geneva has analysed clinical data from more than 1,500 ambulatory patients tested for COVID-19.

The five phases of pandemic care for primary care
The authors present a roadmap for necessary primary care practice transformations to care for patients and communities during the COVID-19 pandemic.

Women almost twice as likely to choose primary care as men
Analysis of osteopathic medical school survey data reveals women are 1.75 times more likely to choose primary care than men, according to a study in The Journal of the American Osteopathic Association.

Spending on primary care vs. other US health care expenditures
National health care survey data were used to assess the amount of money spent on primary care relative to other areas of health care spending in the US from 2002 to 2016.

Read More: Primary Care News and Primary Care Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.